Cabot (CBT) to Release Earnings on Monday

Cabot (NYSE:CBTGet Free Report) is expected to be releasing its earnings data after the market closes on Monday, February 3rd. Analysts expect Cabot to post earnings of $1.74 per share and revenue of $997.11 million for the quarter. Cabot has set its FY 2025 guidance at 7.400-7.800 EPS and its FY25 guidance at $7.40-7.80 EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.

Cabot (NYSE:CBTGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1.01 billion. Cabot had a return on equity of 26.60% and a net margin of 9.51%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period last year, the company posted $1.65 EPS. On average, analysts expect Cabot to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cabot Trading Down 1.0 %

Cabot stock opened at $86.39 on Friday. The stock has a market cap of $4.68 billion, a P/E ratio of 12.82, a PEG ratio of 0.75 and a beta of 1.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08. The firm’s fifty day moving average price is $95.85 and its 200-day moving average price is $102.09. Cabot has a fifty-two week low of $70.63 and a fifty-two week high of $117.46.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.99%. The ex-dividend date of this dividend is Friday, February 28th. Cabot’s dividend payout ratio (DPR) is 25.52%.

Cabot declared that its board has approved a stock buyback plan on Tuesday, December 3rd that allows the company to buyback 10,000,000 outstanding shares. This buyback authorization allows the specialty chemicals company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s board believes its shares are undervalued.

Insider Activity at Cabot

In related news, EVP Jeff Ji Zhu sold 14,566 shares of Cabot stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $113.25, for a total value of $1,649,599.50. Following the completion of the sale, the executive vice president now owns 69,449 shares of the company’s stock, valued at $7,865,099.25. The trade was a 17.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Hobart Kalkstein sold 34,759 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the completion of the transaction, the executive vice president now owns 50,627 shares in the company, valued at $5,833,749.21. This trade represents a 40.71 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,190 shares of company stock valued at $5,751,534. 3.07% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CBT. Mizuho reduced their price target on Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. lowered shares of Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price objective on the stock. in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $102.00.

Check Out Our Latest Research Report on Cabot

About Cabot

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.